- CEO
- Kwang-Jae Kim
- Full Time Employees
- 170
- Sector
- Energy minerals
- Industry
- Coal
- Address
- 38-13, Dongtan-gil Jeongseon-gun GA South Korea 233-902
- IPO Date
- Mar 23, 1990
- Business
- HLB GLOBAL Co., Ltd., previously operating as NEXT SCIENCE Co., Ltd. until its name change in April 2022, and with roots tracing back to its establishment in 1962, engages in a diverse array of business operations. The company plays a significant role in the resource sector, specializing in the methodical collection of premium sea sand and various aggregates, including gravel and fine aggregates, which are then supplied to concrete production facilities through a process that emphasizes stringent cleaning and salt management. Beyond marine resources, HLB GLOBAL extends its reach into media commerce, distributing a wide range of consumer products, from automotive accessories and fragrances to household items, leveraging its digital platforms and content for direct customer engagement. The company also maintains a strong presence in the consumer market with its cosmetics division, which manufactures and sells beauty products and functional health foods, notably through its Elishacoy brand, which offers skincare, sun protection, and hair care items to international markets including the United States, Europe, China, and Japan. Furthermore, HLB GLOBAL is active in the food and beverage retail sector, producing and distributing items such as fermented milk, various teas, confectionery, and jams, prominently featuring its "I'm Alive Kombucha" products, distributed globally. Demonstrating a commitment to environmental innovation, the firm has ventured into smart farm technology since 2021, focusing on ICT-driven solutions like green walls to enhance urban environments and air quality. Strategically, HLB GLOBAL maintains a presence in the biopharmaceutical field, undertaking investments and exploring opportunities in this segment, aligning with the broader HLB Group's significant advancements in developing novel treatments, particularly in oncology, and in-vitro diagnostics. The company is headquartered in Sabuk-eup, South Korea.